BRAF and metastatic melanoma: In this study we tested the clinical applicability of the NGS platform Ion Torrent Personal Genome Machine (Life Technologies, Carlsbad, CA), to simultaneously screen metastatic melanoma patients in order to individuate new or already known SNPs and mutations which could be related with different response duration to BRAF inhibitors.